Literature DB >> 22337564

Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus.

Patricia Katz1, Laura Julian, Mary C Tonner, Jinoos Yazdany, Laura Trupin, Edward Yelin, Lindsey A Criswell.   

Abstract

OBJECTIVE: To examine relationships of obesity and physical inactivity to cognitive impairment in women with systemic lupus erythematosus (SLE).
METHODS: Body composition was measured with dual x-ray absorptiometry (DXA) for 138 women with SLE. Obesity was defined by total percent body fat. Physical activity was ascertained with the self-reported International Physical Activity Questionnaire; inactivity was defined as expenditure of <600 metabolic equivalent minutes/week. Cognitive function was assessed with a 12-index neuropsychological battery. Impairment was defined as age-adjusted Z scores ≤1.5 SDs below the mean on 1 of 3 of tests completed. Scores were obtained for the total battery and for memory and executive function components. Multivariate analyses examined the relationship of obesity and physical activity, individually and combined, to cognitive impairment, controlling for education, race/ethnicity, disease activity, glucocorticoid use, and depression.
RESULTS: Fifteen percent of subjects were cognitively impaired, 28% were physically inactive, and 50% were obese. Five percent of active women were impaired on the executive function battery compared to 23% of those who were inactive (P = 0.003). Obese women were more likely to be impaired on the total battery (6% versus 23%; P = 0.007) and on the executive function portion (2% versus 19%) than nonobese women. In multivariate analysis, both inactivity and DXA-defined obesity were significantly associated with impairment in executive function (inactivity: odds ratio [OR] 9.4, 95% confidence interval [95% CI] 1.7-52.8; obesity: OR 14.8, 95% CI 1.4-151.0).
CONCLUSION: Both obesity and inactivity were significantly and independently associated with impairment in cognitive function. If longitudinal studies show that physical inactivity and obesity are precursors to cognitive impairment, these may become important targets for intervention.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22337564      PMCID: PMC3315616          DOI: 10.1002/acr.21587

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  63 in total

1.  Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.

Authors:  Earl S Ford
Journal:  Epidemiology       Date:  2002-09       Impact factor: 4.822

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report.

Authors:  S D Denburg; R M Carbotte; J A Denburg
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

4.  Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus.

Authors:  Patricia Katz; Steven Gregorich; Jinoos Yazdany; Laura Trupin; Laura Julian; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-02       Impact factor: 4.794

5.  Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study.

Authors:  Marjolein Visser; Stephen B Kritchevsky; Bret H Goodpaster; Anne B Newman; Michael Nevitt; Elizabeth Stamm; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

6.  Assessment of nutritional status and physical activity in systemic lupus erythematosus patients.

Authors:  Fabiana de Miranda Moura dos Santos; Mariane Curado Borges; Maria Isabel Toulson Davisson Correia; Rosa Weiss Telles; Cristina Costa Duarte Lanna
Journal:  Rev Bras Reumatol       Date:  2010 Nov-Dec

7.  Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.

Authors:  Snorri B Rafnsson; Ian J Deary; Felicity B Smith; Martha C Whiteman; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes
Journal:  J Am Geriatr Soc       Date:  2007-05       Impact factor: 5.562

8.  Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.

Authors:  Joseph Walsmith; Leslie Abad; Joseph Kehayias; Ronenn Roubenoff
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

Review 9.  Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment.

Authors:  Maaike Angevaren; Geert Aufdemkampe; H J J Verhaar; A Aleman; Luc Vanhees
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

View more
  19 in total

1.  The vascular phenotype of children with systemic lupus erythematosus.

Authors:  Catherine Quinlan; Jameela Kari; Clarissa Pilkington; John Deanfield; Rukshana Shroff; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-05-23       Impact factor: 3.714

2.  Self-reported and objectively measured physical activity in adults with systemic lupus erythematosus.

Authors:  Grace E Ahn; Joan S Chmiel; Dorothy D Dunlop; Irene B Helenowski; Pamela A Semanik; Jing Song; Barbara Ainsworth; Rowland W Chang; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 3.  Combined Effects of Physical Activity and Obesity on Cognitive Function: Independent, Overlapping, Moderator, and Mediator Models.

Authors:  Yu-Kai Chang; Chien-Heng Chu; Feng-Tzu Chen; Tsung-Min Hung; Jennifer L Etnier
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

4.  Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus.

Authors:  James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

Review 5.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

6.  Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.

Authors:  R Mina; M S Klein-Gitelman; S Nelson; B A Eberhard; G Higgins; N G Singer; K Onel; L Tucker; K M O'Neil; M Punaro; D M Levy; K Haines; J Ying; H I Brunner
Journal:  Lupus       Date:  2014-10-21       Impact factor: 2.911

7.  Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus.

Authors:  James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-01       Impact factor: 4.794

Review 8.  Obesity and episodic memory function.

Authors:  Paul D Loprinzi; Emily Frith
Journal:  J Physiol Sci       Date:  2018-04-17       Impact factor: 2.781

9.  The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR).

Authors:  Phildrich Teh; Bishoy Zakhary; Vaneet K Sandhu
Journal:  Clin Rheumatol       Date:  2018-10-24       Impact factor: 2.980

10.  Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Kashif Jafri; Alexis Ogdie; Atif Qasim; Sarah L Patterson; Milena Gianfrancesco; Zara Izadi; Patricia Katz; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Clin Rheumatol       Date:  2017-10-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.